These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 25847280)

  • 1. Mildronate (Meldonium) in professional sports - monitoring doping control urine samples using hydrophilic interaction liquid chromatography - high resolution/high accuracy mass spectrometry.
    Görgens C; Guddat S; Dib J; Geyer H; Schänzer W; Thevis M
    Drug Test Anal; 2015; 7(11-12):973-9. PubMed ID: 25847280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls.
    Sigmund G; Dib J; Tretzel L; Piper T; Bosse C; Schänzer W; Thevis M
    Drug Test Anal; 2015; 7(11-12):1057-62. PubMed ID: 26481102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The atypical excretion profile of meldonium: Comparison of urinary detection windows after single- and multiple-dose application in healthy volunteers.
    Görgens C; Guddat S; Bosse C; Geyer H; Pop V; Schänzer W; Thevis M
    J Pharm Biomed Anal; 2017 May; 138():175-179. PubMed ID: 28213178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and confirmation of myo-inositol trispyrophosphate (ITPP) in human urine by hydrophilic interaction liquid chromatography high resolution / high accuracy mass spectrometry for doping control purposes.
    Görgens C; Guddat S; Schänzer W; Thevis M
    Drug Test Anal; 2014; 6(11-12):1102-7. PubMed ID: 25070041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening method of mildronate and over 300 doping agents by reversed-phase liquid chromatography-high resolution mass spectrometry.
    Oliveira D; de Araújo A; Ribeiro W; Silva D; Duarte AC; de Sousa V; Pereira HG
    J Pharm Biomed Anal; 2021 Feb; 195():113870. PubMed ID: 33453569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Dilute-and-inject" multi-target screening assay for highly polar doping agents using hydrophilic interaction liquid chromatography high resolution/high accuracy mass spectrometry for sports drug testing.
    Görgens C; Guddat S; Orlovius AK; Sigmund G; Thomas A; Thevis M; Schänzer W
    Anal Bioanal Chem; 2015 Jul; 407(18):5365-79. PubMed ID: 25925859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of anabolic androgenic steroids as sulfate conjugates using high performance liquid chromatography coupled to tandem mass spectrometry.
    Rzeppa S; Heinrich G; Hemmersbach P
    Drug Test Anal; 2015; 7(11-12):1030-9. PubMed ID: 26472592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementing the characterization of in vivo generated N-glucuronic acid conjugates of stanozolol by collision cross section computation and analysis.
    Thevis M; Dib J; Thomas A; Höppner S; Lagojda A; Kuehne D; Sander M; Opfermann G; Schänzer W
    Drug Test Anal; 2015; 7(11-12):1050-6. PubMed ID: 26514814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olodaterol and vilanterol detection in sport drug testing.
    Chundela Z; Große J
    Drug Test Anal; 2015; 7(11-12):980-2. PubMed ID: 26593301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS.
    Thomas A; Walpurgis K; Tretzel L; Brinkkötter P; Fichant E; Delahaut P; Schänzer W; Thevis M
    Drug Test Anal; 2015; 7(11-12):990-8. PubMed ID: 26382721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometric detection of peginesatide in human urine in doping control analysis.
    Möller I; Thomas A; Delahaut P; Geyer H; Schänzer W; Thevis M
    J Pharm Biomed Anal; 2012 Nov; 70():512-7. PubMed ID: 22884786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of designer doping agent--2-ethylamino-1-phenylbutane--in dietary supplements and excretion study following single oral supplement dose.
    Wójtowicz M; Jarek A; Chajewska K; Turek-Lepa E; Kwiatkowska D
    J Pharm Biomed Anal; 2015 Nov; 115():523-33. PubMed ID: 26311473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion studies of meldonium after multidose parenteral application.
    Forsdahl G; Jančić-Stojanović B; Anđelković M; Dikić N; Geisendorfer T; Jeitler V; Gmeiner G
    J Pharm Biomed Anal; 2018 Nov; 161():289-295. PubMed ID: 30189410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches.
    Sigmund G; Koch A; Orlovius AK; Guddat S; Thomas A; Schänzer W; Thevis M
    Drug Test Anal; 2014; 6(11-12):1197-205. PubMed ID: 24913825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meldonium use by athletes at the Baku 2015 European Games.
    Stuart M; Schneider C; Steinbach K
    Br J Sports Med; 2016 Jun; 50(11):694-8. PubMed ID: 27015859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for benfluorex and its major urinary metabolites in routine doping controls.
    Thevis M; Sigmund G; Gougoulidis V; Beuck S; Schlörer N; Thomas A; Kwiatkowska D; Pokrywka A; Schänzer W
    Anal Bioanal Chem; 2011 Aug; 401(2):543-51. PubMed ID: 21116611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meldonium residues in milk: A possible scenario for inadvertent doping in sports?
    Guddat S; Görgens C; Sobolevsky T; Thevis M
    Drug Test Anal; 2021 Nov; 13(11-12):1906-1910. PubMed ID: 34448364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a GC-C-IRMS method for the confirmation analysis of pseudo-endogenous glucocorticoids in doping control.
    de la Torre X; Curcio D; Colamonici C; Molaioni F; Cilia M; Botrè F
    Drug Test Anal; 2015; 7(11-12):1071-8. PubMed ID: 26607312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of GC-EI/MS, GC-EI/MS/MS, LC-ESI/MS/MS, LC-Ag(+) CIS/MS/MS, and GC-ESI/MS/MS for analysis of anabolic steroids in doping control.
    Cha E; Kim S; Kim HJ; Lee KM; Kim KH; Kwon OS; Lee J
    Drug Test Anal; 2015; 7(11-12):1040-9. PubMed ID: 26489966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
    Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W
    Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.